Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
It's important to note that the funding will provided at least 18months of cash flow for the business :-
"Based on the Company's conservative internal estimations for FY2024 and the identified cost savings set out above, the net proceeds of the Fundraise are expected to provide a cash runway of at least 18 months. A key strategic focus for the Company will be seeking to achieve cash neutrality during that timeframe. The Company will continue to seek to take advantage of all grant funding made available to it, which is anticipated to enhance the ability to achieve the runway."
Everything points to the business doing the right things to re-build and re-align the business to move with the times.
Always a risk with any share but I fully believe this company will come good and has the funds at its disposal to do so
therapeutic antibody discovery platform, OptiMAL AIM lab and ITAS could be huge game changers for the business.
Also the fact that the company has restricted remuneration and also reduced head count is also a smart move for the business :-
the Company's non-executive directors having agreed to forgo all remuneration that they are entitled to and the Company's executive directors having agreed to changes in their remuneration to further conserve cash until such time that the Company's trading has recovered to an appropriate level
Happy for others to contribute instead of the "14p" by tomorrow brigade
Shujja what are you basing your prediction on? Fresh air.....
Many stocks do not go below placing price and considering most holders are down significantly I do not foresee this happening
I agree tho patience is required which I have. They have the funding to bring the business to the next level and I am happy to hold with a 6.7 avg
"We are working in a difficult environment for all growth companies at the moment and we fully appreciate the support of our investors, both existing and new. We expect trading to recover incrementally over the short to medium term as we look to progress the launch of the Integrated Therapeutic Antibody Service, and we look forward to updating our shareholders as we go forward with this and our other services."
16-20p fair value IMO at this current price we all have a huge opportunity.
"Short to medium term" being the key here
"In line with the Company's previously announced strategic change to focus on larger integrated service contracts, the Company has engaged with several potential clients for the broader service offering, which has been very positively received. In particular, negotiations concerning a significant order for an integrated service contract have progressed but have not materialised in time for the end of this year. While there is the possibility that negotiations could be completed in the near term, the majority of the revenues would be recognisable in the financial year commencing 1 April 2023."
I am hopeful of an update relating to this from the trading update in the very near future !